The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Oral Administration of ginger-derived Nanolipids Loaded With siRNA As a Novel Approach for Efficient siRNA Drug Delivery to Treat Ulcerative Colitis
Open accessAbstract
AIM: To develop novel siRNA delivery system overcoming the limitations of synthetic nanoparticles, such as potential side effects, nonspecificity and economic production for ulcerative colitis therapy. MATERIALS & METHODS: Nanoparticles composed of edible ginger-derived lipid, termed ginger-derived lipid vehicles (GDLVs) were generated from ginger lipids through hydration of a lipid film, a commonly used method for a liposome fabrication. The morphology, biocompatibility and transfection efficiency of GDLVs loaded with siRNA-CD98 (siRNA-CD98/GDLVs) were characterized by standard methods. RESULTS: Orally administered siRNA-CD98/GDLVs were effectively targeted specifically to colon tissues, resulting in reduced expression of CD98. CONCLUSION: These GDLVs have great promise as efficient siRNA-delivery vehicles while potentially obviating issues related to the traditional synthetic nanoparticles. As such, they help shift the current paradigm of siRNA delivery away from artificially synthesized nanoparticles toward the use of naturally derived nanovehicles from edible plants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
Eaden, J. A., Abrams, K. R., & Mayberry, J. F. (2001) · Gut · doi:10.1136/gut.48.4.526 · Cited by 2,959
Kaser, A., Zeissig, S., & Blumberg, R. S. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101225 · Cited by 1,806
Cancer risk in patients with inflammatory bowel disease: A population-based study
Bernstein, C. N., Blanchard, J. F., Kliewer, E., & Wajda, A. (2001) · Cancer · doi:10.1002/1097-0142(20010215)91:4<854::aid-cncr1073>3.0.co;2-z · Cited by 1,165
Zhang, M., Viennois, E., Prasad, M., Zhang, Y., Wang, L., Zhang, Z., Han, M. K., Xiao, B., Xu, C., Srinivasan, S., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.018 · Cited by 1,026
Self-citationJu, S., Mu, J., Dokland, T., Zhuang, X., Wang, Q., Jiang, H., Xiang, X., Deng, Z.-B., Wang, B., Zhang, L., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.64 · Cited by 862
Mu, J., Zhuang, X., Wang, Q., Jiang, H., Deng, Z., Wang, B., Zhang, L., Kakar, S., Jun, Y., Miller, D., et al. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300729 · Cited by 725
Current and emerging therapeutic targets for IBD
Neurath, M. F. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.208 · Cited by 691
Zhang, M., Xiao, B., Wang, H., Han, M. K., Zhang, Z., Viennois, E., Xu, C., & Merlin, D. (2016) · Molecular Therapy · doi:10.1038/mt.2016.159 · Cited by 456
Self-citationWalker, J. R., Ediger, J. P., Graff, L. A., Greenfeld, J. M., Clara, I., Lix, L., Rawsthorne, P., Miller, N., Rogala, L., McPhail, C. M., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01980.x · Cited by 437
Modulation of Membrane Curvature by Phosphatidic Acid and Lysophosphatidic Acid
Kooijman, E. E., Chupin, V., de Kruijff, B., & Burger, K. N. J. (2003) · Traffic · doi:10.1034/j.1600-0854.2003.00086.x · Cited by 403
Cited by
Plant Exosome-like Nanovesicles: Emerging Therapeutics and Drug Delivery Nanoplatforms
Dad, H. A., Gu, T.-W., Zhu, A.-Q., Huang, L.-Q., & Peng, L.-H. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2020.11.030 · Cited by 745
Plant-derived exosome-like nanoparticles and their therapeutic activities
Kim, J., Li, S., Zhang, S., & Wang, J. (2022) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2021.05.006 · Cited by 396
Lian, M. Q., Chng, W. H., Liang, J., Yeo, H. Q., Lee, C. K., Belaid, M., Tollemeto, M., Wacker, M. G., Czarny, B., & Pastorin, G. (2022) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12283 · Cited by 388
Extracellular Vesicles—Connecting Kingdoms
Woith, E., Fuhrmann, G., & Melzig, M. F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225695 · Cited by 329
Plant-derived extracellular vesicles: a novel nanomedicine approach with advantages and challenges
Nemati, M., Singh, B., Mir, R. A., Nemati, M., Babaei, A., Ahmadi, M., Rasmi, Y., Golezani, A. G., & Rezaie, J. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00889-1 · Cited by 307
Cong, M., Tan, S., Li, S., Gao, L., Huang, L., Zhang, H.-G., & Qiao, H. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.114108 · Cited by 302
Plant‐Derived Vesicle‐Like Nanoparticles as Promising Biotherapeutic Tools: Present and Future
Feng, J., Xiu, Q., Huang, Y., Troyer, Z., Li, B., & Zheng, L. (2023) · Advanced Materials · doi:10.1002/adma.202207826 · Cited by 302
You, J. Y., Kang, S. J., & Rhee, W. J. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.04.023 · Cited by 291
Hwang, J.-H., Park, Y.-S., Kim, H.-S., Kim, D.-H., Lee, S.-H., Lee, C.-H., Lee, S.-H., Kim, J.-E., Lee, S., Kim, H. M., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.071 · Cited by 282
Plant-Derived Exosome-Like Nanovesicles: Current Progress and Prospects
Mu, N., Li, J., Zeng, L., You, J., Li, R., Qin, A., Liu, X., Yan, F., & Zhou, Z. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s420748 · Cited by 265
Li, Z., Wang, H., Yin, H., Bennett, C., Zhang, H.-G., & Guo, P. (2018) · Scientific Reports · doi:10.1038/s41598-018-32953-7 · Cited by 260
Yang, C., Zhang, M., & Merlin, D. (2018) · Journal of Materials Chemistry B · doi:10.1039/c7tb03207b · Cited by 254
Self-citationAdvances in colon-targeted nano-drug delivery systems: challenges and solutions
Naeem, M., Awan, U. A., Subhan, F., Cao, J., Hlaing, S. P., Lee, J., Im, E., Jung, Y., & Yoo, J.-W. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01219-0 · Cited by 248
Alzahrani, F. A., Khan, M. I., Kameli, N., Alsahafi, E., & Riza, Y. M. (2023) · Biomolecules · doi:10.3390/biom13050839 · Cited by 143
“Ginger-derived EVs loaded with siRNA-CD98 have also been found to effectively target colon tissue and reduce the expression of CD98 through oral administration [86].”
BackgroundPlant-Derived Nanovesicles: Further Exploration of Biomedical Function and Application Potential
Li, A., Li, D., Gu, Y., Liu, R., Tang, X., Zhao, Y., Qi, F., Wei, J., & Liu, J. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.12.022 · Cited by 137
Wang, X., Zhang, M., Flores, S. R. L., Woloshun, R. R., Yang, C., Yin, L., Xiang, P., Xu, X., Garrick, M. D., Vidyasagar, S., et al. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.01.003 · Cited by 99
Self-citationExosome-mediated delivery of siRNA molecules in cancer therapy: triumphs and challenges
Ubanako, P., Mirza, S., Ruff, P., & Penny, C. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1447953 · Cited by 68
Metadata
- Authors
- Zhang, M., Wang, X., Han, M. K., Collins, J. F., & Merlin, D.
- Venue
- Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2017-06-30
- Volume
- 12
- Issue
- 16
- Pages
- 1927-1943
- ISSN
- 1743-5889 (ISSN-L)
- 1748-6963
- OpenAlex
- W2724456265
- Cited by
- 302
- References
- 40
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.